Fresenius Medical Care AG & Co. (Pref) (FME) Given a €95.10 Price Target at J P Morgan Chase & Co

J P Morgan Chase & Co set a €95.10 ($111.88) target price on Fresenius Medical Care AG & Co. (Pref) (ETR:FME) in a research note published on Wednesday morning. The brokerage currently has a buy rating on the stock.

A number of other equities analysts also recently issued reports on the company. Goldman Sachs Group, Inc. (The) set a €97.00 ($114.12) price target on Fresenius Medical Care AG & Co. (Pref) and gave the stock a buy rating in a research report on Friday, September 29th. Berenberg Bank set a €95.60 ($112.47) price target on Fresenius Medical Care AG & Co. (Pref) and gave the stock a buy rating in a research report on Tuesday, September 19th. Morgan Stanley set a €90.00 ($105.88) price target on Fresenius Medical Care AG & Co. (Pref) and gave the stock a buy rating in a research report on Friday, September 15th. Citigroup Inc. set a €92.00 ($108.24) price target on Fresenius Medical Care AG & Co. (Pref) and gave the stock a buy rating in a research report on Tuesday, August 8th. Finally, Deutsche Bank AG set a €84.00 ($98.82) price target on Fresenius Medical Care AG & Co. (Pref) and gave the stock a neutral rating in a research report on Tuesday, August 8th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and ten have assigned a buy rating to the stock. The stock currently has a consensus rating of Hold and a consensus price target of €88.39 ($103.98).

Fresenius Medical Care AG & Co. (ETR FME) traded down 0.418% on Wednesday, hitting €81.051. The stock had a trading volume of 120 shares. The stock has a market cap of €24.87 billion and a P/E ratio of 20.900. Fresenius Medical Care AG & Co. has a 12 month low of €70.82 and a 12 month high of €89.07. The company’s 50 day moving average is €80.95 and its 200-day moving average is €82.10.

ILLEGAL ACTIVITY WARNING: This story was reported by Markets Daily and is the sole property of of Markets Daily. If you are accessing this story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The original version of this story can be viewed at https://www.themarketsdaily.com/2017/10/12/fresenius-medical-care-ag-95-10-price-target-at-j-p-morgan-chase-co.html.

Fresenius Medical Care AG & Co. (Pref) Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. (Pref) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. (Pref) and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply